| Bioactivity | Kahalalide A is an anti-mycobacterial compound with antimicrobial activity. Kahalalide A is derived from the marine mollusk Elysia rufescens. Kahalalide A has attracted extensive attention in natural product research due to its potential medicinal value[1]. |
| CAS | 179733-11-0 |
| Sequence | {N-[(2S)-2-methyl-1-oxobutyl]}-{d-Phe}-Thr-{d-Leu}-{d-Phe}-{d-Leu}-Thr-Ser |
| Shortening | {N-[(2S)-2-methyl-1-oxobutyl]}-{d-Phe}-T-{d-Leu}-{d-Phe}-{d-Leu}-TS |
| Formula | C46H67N7O11 |
| Molar Mass | 894.06 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Solid-phase synthesis in the twenty-first century |
Kahalalide A
CAS: 179733-11-0 F: C46H67N7O11 W: 894.06
Kahalalide A is an anti-mycobacterial compound with antimicrobial activity. Kahalalide A is derived from the marine moll
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.